Financial Summary (All financials)
| In millions, except per share items | Apr-29-23 | Apr-30-22 | Apr-30-21 | Apr-30-20 |
| Revenues | 184.2 | 106.5 | 58.7 | 53.8 |
| Revenue growth | 73.0% | 81.4% | 9.0% | |
| Cost of goods sold | 78.0 | 42.5 | 20.4 | 7.7 |
| Gross profit | 106.2 | 64.0 | 38.3 | 46.1 |
| Gross margin | 57.7% | 60.1% | 65.2% | 85.6% |
| Selling, general and administrative | 48.2 | 34.9 | 28.7 | 16.5 |
| Research and development | 76.8 | 47.9 | 34.8 | 27.6 |
| EBIT | -18.8 | -18.8 | -25.2 | 2.1 |
| EBIT margin | -10.2% | -17.7% | -43.0% | 3.8% |
| Pre-tax income | -17.9 | -22.2 | -25.3 | 2.1 |
| Income taxes | -1.4 | 0.0 | 2.2 | 0.8 |
| Tax rate | 7.6% | 0.2% | | 36.6% |
| Net income | -16.5 | -22.2 | -27.5 | 0.0 |
| Net margin | -9.0% | -20.8% | -46.9% | 0.0% |
| |
| Diluted EPS | ($0.11) | ($0.25) | ($0.40) | $0.00 |
| Shares outstanding (diluted) | 147.1 | 88.4 | 69.1 | 71.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|